Benchmark analyst David Williams maintains Rigetti Computing (NASDAQ:RGTI) with a Buy and lowers the price target from $10 to $8.
4D pharma To Stop Testing Asthma Med in COVID-19 Patients
4D pharma plc (NASDAQ: LBPS) has completed its target enrollment of 30 patients for Part A of its Phase 1/2 trial of MRx-4DP0004 in patients with partly controlled asthma.